Delivery Order SPE2DB20D2014-SPE2DB24FC95U
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,081.74 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of letrozole 2.5 mg tablets, a medication used to treat breast cancer. This is a firm-fixed-price contract with a period of performance through February 4, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,411.05, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 14, 2025. This award does not have a set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $10,987.95 firm fixed-price contract is for the delivery of 4,565,698,837 units of the prescription drug Letrozole 2.5 mg Tablets, packaged in 30-count supplies. The contract has a completion date of September 6, 2024. Amerisourcebergen is a major pharmaceutical distributor to the U.S. federal government, holding several...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.12 firm-fixed-price delivery order contract is for the supply of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract has an ultimate completion date of October 30, 2024 and does not include any set-aside designations, indicating open competition. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,612.74, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract is a Delivery Order type with a Firm Fixed Price pricing mechanism, and has an ultimate completion date of February 14, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.40 firm fixed-price delivery order is for 4,567,524,174 units of Letrozole 2.5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,219.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.85, is for the delivery of letrozole 2.5mg medication tablets. It is a firm fixed-price, non-set-aside contract with a performance period extending through May 1, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.56 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, with an ultimate completion date of November 5, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,411.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication commonly used in the treatment of certain types of breast cancer. The contract is a Firm Fixed Price Delivery Order with a performance period extending through February 2025. AmerisourceBergen holds a significant...